In autoimmune diseases, hyperactive gp130/STAT signaling leads to augmented inflammatory arthritis through increased infiltrating T cells in the joints (27), and blockade of gp130 activities by therapeutic antibodies has been proposed as a potential therapy in RA (28). Here, IL6ST is linked to autoimmune disease.